Original language | English |
---|---|
Pages (from-to) | 487-502 |
Number of pages | 16 |
Journal | Heart, lung & circulation |
Volume | 20 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2011 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. / Chew, Derek P.; Aroney, Constantine N.; Aylward, Philip E.; Kelly, Anne Maree; White, Harvey D.; Tideman, Philip A.; Waddell, Jill; Azadi, Leva; Wilson, Alison J.; Ruta, Leah Anne M.
In: Heart, lung & circulation, Vol. 20, No. 8, 08.2011, p. 487-502.Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006.
AU - Chew, Derek P.
AU - Aroney, Constantine N.
AU - Aylward, Philip E.
AU - Kelly, Anne Maree
AU - White, Harvey D.
AU - Tideman, Philip A.
AU - Waddell, Jill
AU - Azadi, Leva
AU - Wilson, Alison J.
AU - Ruta, Leah Anne M
N1 - Funding Information: Derek Chew has received travel assistance, speaker fees or been on the advisory board for Astra Zeneca Australia, Eli-Lilly Australia and Sanofi Aventis Australia. Con Aroney has received travel assistance from Boehringer Ingel-heim. Philip Aylward has received research honoraria, research grants, travel assistance or been on advisory boards for Boehringer Ingelheim, Astra Zeneca, Eli-Lilly, CSL, Merck Sharp & Dohme, Pfizer, Sanofi Aventis. Philip Tideman has received speakers honoraria from Roche Diagnostics Australia. Harvey White has received research grants from Sanofi Aventis, Eli-Lilly, The Medicines Company, National Institutes of Health, Pfizer, Roche, Johnson & Johnson, Schering Plough, Merck Sharp & Dohme, Astra Zeneca, Daiichi Sankyo Pharma Development, Bristol-Myers Squibb and consulting fees from Regado Biosciences. Anne-Maree Kelly is a member of advisory boards to Astra Zeneca and Merck Sharp & Dohme and has received travel assistance from Radiometer Pty Ltd, is the Senior Clinical Advisor for the Emergency Care Improvement and Innovation Clinical Network (Department of Health Victoria), is on the editorial boards of Emergency Medicine Australasia, Annals of Emergency Medicine and Hong Kong Journal of Emergency Medicine and conducts research in acute cardiology and biomarkers.
PY - 2011/8
Y1 - 2011/8
UR - http://www.scopus.com/inward/record.url?scp=79961201480&partnerID=8YFLogxK
U2 - 10.1016/j.hlc.2011.03.008
DO - 10.1016/j.hlc.2011.03.008
M3 - Review article
C2 - 21910262
AN - SCOPUS:79961201480
VL - 20
SP - 487
EP - 502
JO - Heart, lung & circulation
JF - Heart, lung & circulation
SN - 1443-9506
IS - 8
ER -